# Cardiologist-Administered Midazolam vs. Anaesthesiologist-Assisted Propofol Sedation For Transoesophageal Echocardiography-Guided Cardioversion of Atrial Fibrillation

Study · id `cardio:ct-nct07571447` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07571447](<https://clinicaltrials.gov/study/NCT07571447>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07571447

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 220 participants.

## Technical summary

Registry record NCT07571447. Randomized; no masking; primary purpose health services research. Start 2026-09 (anticipated); primary completion 2027-09 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose health services research
- Phase: Phase 4
- Enrolled: 220 participants (planned count; ClinicalTrials.gov record NCT07571447, source copy `cardio:ctgov-nct07571447-2026-07-08`, retrieved 2026-10-26)
- Planned start: 2026-09 (anticipated) (ClinicalTrials.gov record NCT07571447, source copy `cardio:ctgov-nct07571447-2026-07-08`, retrieved 2026-10-26)
- Primary completion: 2027-09 (anticipated) (ClinicalTrials.gov record NCT07571447, source copy `cardio:ctgov-nct07571447-2026-07-08`, retrieved 2026-10-26)
- Completion: 2027-09 (anticipated) (ClinicalTrials.gov record NCT07571447, source copy `cardio:ctgov-nct07571447-2026-07-08`, retrieved 2026-10-26)
- Countries: Denmark (ClinicalTrials.gov record NCT07571447, source copy `cardio:ctgov-nct07571447-2026-07-08`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "NOT\_YET\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07571447-2026-07-08`, retrieved 2026-10-26)

## The registry's words

- Brief title: Cardiologist-Administered Midazolam vs. Anaesthesiologist-Assisted Propofol Sedation For Transoesophageal Echocardiography-Guided Cardioversion of Atrial Fibrillation
- Acronym: CARDIOZOLAM-1
- Condition: Atrial Fibrillation (AF)
- Condition: Atrial Flutter
- Intervention (Other): One-step cardiologist-only midazolam sedation
- Intervention (Other): Two-step anaesthesiologist-assisted propofol sedation
- Lead sponsor: Gødstrup Hospital
- Lead sponsor class: OTHER
- Collaborator: University of Aarhus
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry condition terms include this condition: Atrial flutter (`cardio:atrial-flutter`)
- Registry lists this organization as the lead sponsor: Gødstrup Hospital (`cardio:org-gdstrup-hospital-114fb1`)
- Registry lists this organization as a collaborator: University of Aarhus (`cardio:org-university-of-aarhus`)

## Provenance

Content hash: 8f9ba4e0eee88cf64ba90740902ce7952683aa9040f48941187ddb14b54d3c72
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
